Adaptin Bio, Inc.
Biotechnology company · Charlotte, North Carolina, United States · OTC: APTN
Adaptin Bio, Inc. is a biotechnology company headquartered in Charlotte, North Carolina, United States. Its earliest recorded incorporation is in 2022. Its shares trade on OTC under the ticker APTN. It has reported private securities offerings to the US SEC, most recently $1.9 million sold in a notice filed in 2026.
Adaptin Bio at a glance
What does Adaptin Bio do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $1.9 million sold (2026).
Frequently asked questions about Adaptin Bio
Where is Adaptin Bio headquartered?
Adaptin Bio, Inc. is headquartered in Charlotte, North Carolina, United States.
What does Adaptin Bio do?
Adaptin Bio, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Adaptin Bio a public company?
Yes. Adaptin Bio, Inc. trades on OTC under the ticker APTN.
When was Adaptin Bio founded?
The earliest incorporation on record for Adaptin Bio, Inc. is in 2022, according to public company registers.
Similar companies
- Chelsea Therapeutics International, Ltd.Charlotte, North Carolina, United States
- Sonablate Corp.Charlotte, North Carolina, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences